type here...

CATEGORIES

Patient Zone

LATEST

1...789...60Page 8 of 60

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

A Mother’s Fight for Life and a Few More Weeks With Her Sons #tofersen4lisa

Medika Life -
Lisa Stockman-Mauriello is dying from ALS, but a pharmaceutical company, Biogen, is trialing a new drug called Torfersen that may buy her a little extra time.

Does Artificial Intelligence (#AI) Chatbot Outperform Physicians in Patient Experience?

Gil Bashe, Medika Life Editor -
JAMA Article Draws Fire for Its Research Biases on ChatGPT and Chatbot - But Should We Ignore Its Conclusions Altogether?

Suicide and Self-Harm Enablers Are Out There Now

Pat Farrell PhD -
As in other psychiatric hospitals, there are always those patients who are willing to share any number of ways to commit self-harm or suicide.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories